p.A53T SNCA帕金森病与典型帕金森病的选择性认知障碍和嗅觉减退比较
研究比较了18例A53T帕金森病与18例年龄、性别和病程匹配的典型帕金森病患者的非运动症状,发现A53T组左旋多巴等效日剂量更高,嗅觉识别、线段方向判断、字母数字排序和音位词语流畅性评分更低,而整体认知、言语记忆和语义流畅性两组相似。结论认为选择性认知障碍反映额顶网络功能障碍,与嗅觉受损共同构成A53T帕金森病相关的一组非运动功能障碍。
要点
- A53T帕金森病组左旋多巴等效日剂量高于典型帕金森病组(p=0.018)。
- A53T组嗅觉识别、线段方向判断、字母数字排序和音位词语流畅性评分低于典型组。
- 两组整体认知、言语记忆和语义流畅性相似,A53T表现为选择性认知障碍。
核心结论
- A53T帕金森病表现为选择性认知障碍(反映额顶网络功能障碍)合并嗅觉受损,构成一组相关非运动功能障碍,对A53T帕金森病患者预后有提示意义,并可能为典型帕金森病提供线索。
研究设计与样本
- 研究纳入18例A53T帕金森病患者和18例年龄、性别及病程匹配的典型帕金森病患者,均来自帕金森病进展标志物计划研究,采用标准化问卷和效度量表评估嗅觉减退、神经精神、自主神经和睡眠障碍。
主要发现
- A53T帕金森病组左旋多巴等效日剂量高于典型帕金森病组(p=0.018)。
- A53T帕金森病组宾夕法尼亚大学嗅觉识别测验评分低于典型帕金森病组(p=0.001)。
- A53T帕金森病组Benton线段方向判断测验评分低于典型帕金森病组(p=0.001)。
- A53T帕金森病组字母数字排序测验评分低于典型帕金森病组(p=0.002)。
- A53T帕金森病组音位词语流畅性评分低于典型帕金森病组(p=0.002),而整体认知、言语记忆和语义流畅性两组相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate nonmotor symptoms in early SNCA/p.A53T Parkinson disease (PD) (A53T PD) compared to typical PD (tPD). METHODS: The presence of hyposmia, neuropsychiatric, dysautonomic, and sleep disturbances was assessed by standardized questionnaires and validated scales in 18 patients with A53T PD and 18 patients with tPD, matched for age, sex, and disease duration. All patients were enrolled into the Parkinson's Progression Markers Initiative study. RESULTS: The levodopa equivalent daily dose was higher in the A53T PD (p = 0.018) group vs the tPD group. Scores on the University of Pennsylvania Smell Identification Test (p = 0.001), Benton Judgement of Line Orientation test (p = 0.001), Letter Number Sequencing Test (p = 0.002), and phonemic verbal fluency (p = 0.002) were lower in the A53T PD group vs the tPD group. In contrast, overall cognition, verbal memory, and semantic fluency were similar between groups. CONCLUSION: The observed selective cognitive impairment reflecting frontal-parietal network dysfunction, together with impaired olfaction, define a set of nonmotor dysfunctions related to A53T PD. These results have implications for the prognosis of patients with A53T PD. Moreover, as the archetypal α-synucleinopathy, such results may give insights into tPD.
引用
- Koros C, Stamelou M, Simitsi A, et al. Selective cognitive impairment and hyposmia in p.A53T SNCA PD vs typical PD. Neurology. 2018. PMID: 29438043. doi:10.1212/WNL.0000000000005063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。